Email this article Experience of use of human leukocyte interferon in remittent course of multiple sclerosis
- Authors: Zavalishin I.A.1,2, Khaidarov В.Т.1,2, Zakharova М.N.1,2, Adarcheva L.S.1,2, Niyazbekova А.S.1,2, Kuznetsov V.P.1,2, Belyaev D.L.1,2, Babayants А.А.1,2
-
Affiliations:
- Research Institute of Neurology, Russian Academy of Medical Sciences
- NIIEM named after N.F. Gamalei RAMS
- Issue: Vol XXIX, No 1-2 (1997)
- Pages: 58-61
- Section: Articles
- URL: https://journal-vniispk.ru/1027-4898/article/view/79895
- DOI: https://doi.org/10.17816/nb79895
- ID: 79895
Cite item
Full Text
Abstract
Results of follow up of 58 patients with remittent type of course of multiple sclerosis, who were treated with human leukocyte interferon for 3 years are presented. Improvement in the course of disease of incidence of aggravation and neurological deficite, normalization of cytokines allows to recommend human leucocyte interferon for treatment of multiple sclerosis.
Keywords
Full Text
##article.viewOnOriginalSite##About the authors
I. A. Zavalishin
Research Institute of Neurology, Russian Academy of Medical Sciences; NIIEM named after N.F. Gamalei RAMS
Author for correspondence.
Email: info@eco-vector.com
Russian Federation, Moscow; Moscow
В. Т. Khaidarov
Research Institute of Neurology, Russian Academy of Medical Sciences; NIIEM named after N.F. Gamalei RAMS
Email: info@eco-vector.com
Russian Federation, Moscow; Moscow
М. N. Zakharova
Research Institute of Neurology, Russian Academy of Medical Sciences; NIIEM named after N.F. Gamalei RAMS
Email: info@eco-vector.com
Russian Federation, Moscow; Moscow
L. S. Adarcheva
Research Institute of Neurology, Russian Academy of Medical Sciences; NIIEM named after N.F. Gamalei RAMS
Email: info@eco-vector.com
Russian Federation, Moscow; Moscow
А. S. Niyazbekova
Research Institute of Neurology, Russian Academy of Medical Sciences; NIIEM named after N.F. Gamalei RAMS
Email: info@eco-vector.com
Russian Federation, Moscow; Moscow
V. P. Kuznetsov
Research Institute of Neurology, Russian Academy of Medical Sciences; NIIEM named after N.F. Gamalei RAMS
Email: info@eco-vector.com
Russian Federation, Moscow; Moscow
D. L. Belyaev
Research Institute of Neurology, Russian Academy of Medical Sciences; NIIEM named after N.F. Gamalei RAMS
Email: info@eco-vector.com
Russian Federation, Moscow; Moscow
А. А. Babayants
Research Institute of Neurology, Russian Academy of Medical Sciences; NIIEM named after N.F. Gamalei RAMS
Email: info@eco-vector.com
Russian Federation, Moscow; Moscow
References
- Жученко Т.Д., Завалишин И.А. // Неврология. журнал.—1996.—№ 1.—С.37—44.
- Чекнев С.Б. // Иммунология.—1994.—N 2.—С.9—17.
- Brosnan C.F., Cannella В., Battisfini L. // Neurology.— 1995.—Vol.45.—P.16—22.
- Camenga D.L., Johnson K.P., Milton F. et al. // Arch. Neurol.—1986.—Vol.43.—P.1239—1246.
- Durelli L., Bongyoanni M.R., Cavallo R. // Neurology.— 1994.—Vol.44.—P.406—413.
- Link J., Sоderstrоm. M., Olsson T. et al. // Ann.Neurol.— 1994.—Vol.36.—P.379—386.
- Lucas K., Hohfeld R. // Neurology.—1995.—Vol.45.—P.4—6.
- Miller A., Honigman S. In: Abramsky O., Ovadia H., eds.: Martin Dunitz Ltd. Frontiers in multiple Sclerosis: Clinical Research and Therapy.—1997.—P.195—205.
- Panitch H.S. Drugs.—1992.—Vol.44.—P. 946—962.
- Paty D.W., Li D.K. // Neurology.—1993.—Vol. 43.— P.662—667.
- Selmaj K.,Raine C., Canntlla В. // J.Clin. Invest.—1991.— Vol87.—P. 949—954.
- Sharief M.K., Hentger R. // N.Engl. J. Med.—1991.— Vol.325.—P.467—472.
Supplementary files
